A trial looking at AZD6738 and durvalumab for early breast cancer (PARTNERING)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for people who are already taking part in the PARTNER trial. It is for people with triple negative breast cancer, or breast cancer with a change in the BRCA gene. Triple negative breast cancer are cancers that don’t have receptors to:

Cancer Research UK supports this trial.

Recruitment start: 1 April 2019

Recruitment end: 19 February 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Jean Abraham

Supported by

AstraZeneca

Cambridge University Hospitals NHS Foundation Trust

Cancer Research UK

University of Cambridge

Last reviewed: 13 March 2024

CRUK internal database number: 16141

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.